Pharmaceutical Drugs Market By Segments (Musculoskeletal Disorders Drugs, Cardiovascular Drugs, Oncology Drugs, Anti-Infective Drugs, Metabolic Disorder Drugs, Central Nervous System Drugs, Genito-Urinary Drugs, Respiratory Diseases Drugs, Gastrointestinal Drugs, Hematology Drugs, Dermatology Drugs, Ophthalmology Drugs) - Global Forecast To 2022

Starting Price : $ 6000.00 $ 4020.00 | Pages : 430 | Published : July 2018 | SKU CODE : o&s005 | Format :

Request Sample

Pharmaceutical Drugs Market Definition

The pharmaceutical industry develops drugs to diagnose, cure, treat or prevent diseases. Pharmaceutical drugs are subjected to various laws and regulations that deal with patenting, testing, safety, efficacy and marketing.

Pharmaceutical companies produce pharmaceutical drugs made from active pharmaceutical ingredients (API) and excipients.

Pharmaceutical preparations are drugs intended for human or veterinary use presented in their finished dosage form. Companies engaged in pharmaceutical preparations are involved in drug discovery and development, manufacturing, drug processing and sales and marketing of drugs for human or veterinary use. Tablets, ampoules, capsules, ointments and medicinal powders and solutions are the various pharmaceutical preparations produced by pharmaceutical companies.

Pharmaceutical Drugs Market Size

The global pharmaceutical drug market was worth $934.8 billion in 2017 and has grown at a CAGR of 5.16% during 2013-2017. The market is expected to grow at a CAGR of 5.78% during 2017-2021 and is forecast to be worth $1,170.4 billion by 2021. Aging populations, income growth especially in emerging economies and the high prices of new drugs are factors leading to steadily increasing per capita drugs expenditure.

Pharmaceutical Drugs Market Drivers

The Key drivers of the pharmaceutical drugs market include:

New Methods For Drug Discovery – Stem cells and organ on chip technologies are changing the way drug trials are being conducted. Organ on chips are micro-engineered biometric systems that simulates activities, mechanics and physiological response of organ systems. Drug trial processes such as target identification, validation, target based screening and phenotypic screening are being done through organ on chip and stem cell technologies. These technologies are considerably reducing the drug discovery costs and generating reliable predictions on drug efficiency and human safety. Therefore, low drug discovery costs and accurate results generated from these technologies is expected to drive the pharmaceutical drugs market.

Pharmaceutical Drugs Market Restraints

The key restraint on the pharmaceutical drugs market include:

High Costs of Drug Approval – Drug approval involves series of research stages and regulatory approvals that are often expensive. Drug approval process include about four phases of clinical trials and various stages of screening process with the regulatory body such as FDA. The costs of failed clinical trials is also high as clinical trial phases involves huge investments. According to Tufts Center for the Study of Drug Development, the cost of bringing a new drug from its conception to shelves is about $2.7 billion in 2017. This cost has increased more than 10 folds, with the cost of bringing a new drug to the market being $320 million in 1990s.  thus indicating high drug approval costs, which affected the growth of the pharmaceutical drugs market.

Pharmaceutical Drugs Market Trends

Major trends influencing the pharmaceutical drugs include:

Early Rx-To-OTC Switch-Early Rx-to-OTC switch, or switching the product from prescription to non-prescription status, is a key trend in the dermatology drugs market. Traditionally, the Rx-to-OTC status conversion usually took place at a time nearing the patent expiry or after. However, forward-thinking companies are now looking at switching from Rx-to-OTC well in advance of the patent expiry of the drug. This helps the manufacturer to capitalize on the market opportunities for the product. Early Rx-to-OTC switching also provides an additional benefit as a way to recover all the expenses incurred on the product by the company. A key example from the dermatology OTC drugs market for an early switch includes butenafine hydrochloride (Lotrimin Ultra), an anti-fungal drug. The product was reclassified and switched to being an OTC drug in December 2001, long before its patent expiry (April 2017). It is used in the treatment of athlete’s foot, jock itch and ringworm infections.

Increase In Personalized Medicine - There has been an increasing push towards the development of personalized medicine. Personalized medicine is also referred to as precision medicine, the idea of which is to provide medical care according to patient’s individual characteristics, needs, preferences and genetic makeup. According to a survey by the Tufts Center, 94% of pharmaceutical companies have invested in personal medicine research. For instance, Bayer is investing in personalized medicine for the development of therapies for cardiovascular diseases.

Pharmaceutical Drugs Market Segmentation

The Pharmaceutical drugs market is segmented by specialty, and by geography.
By Specialty - The pharmaceutical drugs market is segmented by specialty into
    • a) Musculoskeletal Disorders Drugs
    • b) Cardiovascular Drugs
    • c) Oncology Drugs
    • d) Anti-infective Drugs
    • e) Metabolic Disorders Drugs
    • f) Central Nervous System Drugs
    • g) Genito-urinary Drugs
    • h) Respiratory Diseases Drugs
    • i) Gastrointestinal Drugs
    • j) Hematology Drugs
    • k) Dermatology Drugs
    • l) Ophthalmology Drugs
Metabolic Disorders Drugs had the highest growth rate of nearly 11.59% during the historic period. The fastest growth in the historic period can be attributed to the growing diabetic population worldwide, and increasing academia-industry collaborations to develop new drugs for treatment of metabolic disorders.
By Sub-segment - The musculoskeletal disorders drugs market is segmented by sub-segment into
    • a) Drugs For Rheumatoid Arthritis
    • b) Muscle Relaxants
    • c) Others
The cardiovascular drugs market is segmented by sub-segment into
    • a) Anti-hypertensive Drugs
    • b) Hypolipidemics
    • c) Anti Thrombotics
    • d) Other Drugs For Cardiovascular Diseases
The oncology drugs market is segmented by sub-segment into
    • a) Blood cancer
    • b) Breast cancer
    • c) Cervical Cancer
    • d) Lung cancer
    • e) Colorectal Cancer
    • f) Non-Small Cell Lung Cancer
    • g) Prostate cancer
    • h) Kidney Cancer
    • i) Gastric Cancer
    • j) Brain Tumor
    • k) Pancreatic cancer
    • l) Skin cancer
    • m) Ovarian cancer
    • n) Thyroid cancer
    • o) Bladder Cancer
    • p) Others
The anti-infective drugs market is segmented by sub-segment into
    • a) Antivirals
    • b) Antibiotics
    • c) Antifungals
    • d) Antiparasitics
The metabolic disorders drugs market is segmented by sub-segment into
    • a) Anti diabetics drugs
    • b) Anti-thyroid drugs
    • c) Others (Hyperparathyroidism, Hypopituitarism, Hypoadrenalism)
The central nervous system drugs market is segmented by sub-segment into
    • a) Anaesthetics
    • b) Analgesics
    • c) Anti-Parkinson drugs
    • d) Anti-Epileptics
    • e) Other CNS drugs
The genito-urinary drugs market is segmented by sub-segment into
Hormonal contraceptives
    • a) Drugs For Hormonal Replacement Therapy
    • b) Drugs For Infections And Others
    • c) Drugs for Benign prostatic hypertrophy
    • d) Drugs For Erectile Dysfunction
    • e) Drugs For Urinary Incontinence And Overactive Bladder
    • f) Drugs for Infertility
    • g) Diuretics
The respiratory diseases drugs market is segmented by sub-segment into
    • a) Anti-Asthmatics And COPD Drugs
    • b) Cough and cold Preparations
The gastrointestinal drugs market is segmented by sub-segment into
    • a) Antiulcerants
    • b) Vitamin And Minerals
    • c) Antacids
    • d) Antiemetics And Antinauseants
    • e) Antiobesity
    • f) Antidiarrhoeals
The hematology drugs market is segmented by sub-segment into
    • a) Blood Products
    • b) Anemia And Other Blood Disorder Drugs
The ophthalmology drugs market is segmented by sub-segment into
    • a) Antiglaucoma Drugs
    • b) Dry Eye Medication
    • c) Other Ophthalmological Drugs (Retinal Disorders, Anti-Infectives/Allergy)
By Geography - The pharmaceutical drugs market is segmented into
    • o North America
      • USA
    • o Western Europe
      • UK
      • Germany
      • France
      • Spain
      • Italy
    • o Asia Pacific
      • China
      • Japan
      • India
      • Australia
    • o Eastern Europe
      • Russia
    • o South America
      • Brazil
    • o Middle East
    • o Africa
North America is the largest market for pharmaceutical drugs, accounting for 36.5% of the global market. It was followed by Asia-Pacific, Western Europe, and then the other regions. Going forward, Asia-Pacific and Middle East will be the fastest growing regions in this market.

Pharmaceutical Drugs Competitive Landscape

Major Competitors are:
    • • Novartis AG
    • • Sanofi S.A.
    • • Pfizer Inc.
    • • Gilead Sciences, Inc.
Other Competitors Include:
    • • Johnson & Johnson
    • • GlaxoSmithKline Plc.
    • • Bayer AG
    • • Teva Pharmaceuticals
    • • Merck & Co.

  1. 1. Executive Summary
  2. 2. Pharmaceutical Drugs Market Characteristics
  3. 3. Global Pharmaceutical Drugs Market Size And Growth
    • 3.1. Global Pharmaceutical Drugs Historic Market Growth
      • 3.1.1. Drivers Of The Market
      • 3.1.2. Restraints On The Market
    • 3.2. Global Pharmaceutical Drugs Market Forecast Growth
      • 3.2.1. Drivers Of The Market
      • 3.2.2. Restraints On The Market
  4. 4. Global Pharmaceutical Drugs Market, PESTLE Analysis
    • 4.1. Political
    • 4.2. Economic
    • 4.3. Social
    • 4.4. Technological
    • 4.5. Legal
    • 4.6. Environmental
  5. 5. Pharmaceutical Drugs Market Customer Information
  6. 6. Pharmaceutical Drugs Market Regional And Country Analysis
    • 6.1. Pharmaceutical Drugs Market, 2017, Split By Region
    • 6.2. Pharmaceutical Drugs Market, 2013-2017, Historic And Forecast Growth Rate, Split By Region
    • 6.3. Pharmaceutical Drugs Market, 2017, Split By Country
    • 6.4. Pharmaceutical Drugs Market, 2013-2017, Historic And Forecast Growth Rate, By Country
  7. 7. Global Pharmaceutical Drugs Market Segmentation
    • 7.1. Global Pharmaceutical Drugs Market, Split By Segments, 2017, $ Billion
      • 7.1.1. Musculoskeletal Disorders Drugs
      • 7.1.2. Cardiovascular Drugs
      • 7.1.3. Oncology Drugs
      • 7.1.4. Anti-infective Drugs
      • 7.1.5. Metabolic Disorder Drugs
      • 7.1.6. Central Nervous System Drugs
      • 7.1.7. Genito-urinary Drugs
      • 7.1.8. Respiratory Drugs
      • 7.1.9. Gastrointestinal Drugs
      • 7.1.10. Hematology Drugs
      • 7.1.11. Dermatology Drugs
      • 7.1.12. Ophthalmology Drugs
    • 7.2. Global Pharmaceutical Drugs Market, 2013-2017, Historic And Forecast Growth Rate, Split By Segments
  8. 8. Pharmaceutical Drugs Market Segments And Subsegments
    • 8.1. Musculoskeletal Disorders Drugs
      • 8.1.1. Musculoskeletal Disorders Drugs Market Characteristics
      • 8.1.2. Musculoskeletal Disorders Drugs Market Trends & Strategies
      • 8.1.3. Global Musculoskeletal Disorders Drugs Market, By Subsegment
      • 8.1.3.1. Drugs for Rheumatoid Arthritis
      • 8.1.3.2. Muscle Relaxants
      • 8.1.3.3. Others
      • 8.1.4. Global Musculoskeletal Disorders Drugs Market, 2013-2017, Historic And Forecast Growth Rate, By Subsegment
      • 8.1.5. Global Musculoskeletal Drugs Market Competitive Landscape
      • 8.1.6. Global Musculoskeletal Drugs Market Key Mergers And Acquisitions
    • 8.2. Cardiovascular Drugs
      • 8.2.1. Cardiovascular Drugs Market Characteristics
      • 8.2.2. Cardiovascular Drugs Market Trends & Strategies
      • 8.2.3. Global Cardiovascular Drugs Market, Segmentation By Subsegment
      • 8.2.3.1. Anti-hypertensive Drugs
      • 8.2.3.2. Hypolipidemics
      • 8.2.3.3. Anti Thrombotics
      • 8.2.3.4. Other Drugs For Cardiovascular Diseases
      • 8.2.4. Global Cardiovascular Drugs Market, 2013-2017, Historic And Forecast Growth Rate, By Subsegment
      • 8.2.5. Global Cardiovascular Drugs Market Competitive Landscape
      • 8.2.6. Global Cardiovascular Drugs Market Key Mergers And Acquisitions
    • 8.3. Oncology Drugs
      • 8.3.1. Oncology Drugs Market Characteristics
      • 8.3.2. Oncology Drugs Market Trends & Strategies
      • 8.3.3. Global Oncology Drugs Market, Segmentation By Subsegment
      • 8.3.3.1. Blood Cancer
      • 8.3.3.2. Breast Cancer
      • 8.3.3.3. Cervical Cancer
      • 8.3.3.4. Lung Cancer
      • 8.3.3.5. Colorectal Cancer
      • 8.3.3.6. Non-Small Cell Lung Cancer
      • 8.3.3.7. Prostate Cancer
      • 8.3.3.8. Kidney Cancer
      • 8.3.3.9. Gastric Cancer
      • 8.3.3.10. Brain Tumor
      • 8.3.3.11. Pancreatic Cancer
      • 8.3.3.12. Skin Cancer
      • 8.3.3.13. Ovarian Cancer
      • 8.3.3.14. Bladder Cancer
      • 8.3.3.15. Thyroid Cancer
      • 8.3.3.16. Others
      • 8.3.4. Global Oncology Drugs Market, 2013-2017, Historic And Forecast Growth Rate, By Subsegment
      • 8.3.5. Global Oncology Drugs Market Competitive Landscape
      • 8.3.6. Global Oncology Drugs Market Key Mergers And Acquisitions
    • 8.4. Anti-Infective Drugs
      • 8.4.1. Anti-infective Drugs Market Characteristics
      • 8.4.2. Anti-infective Drugs Market Trends & Strategies
      • 8.4.3. Global Anti-Infective Drugs Market, Segmentation By Subsegment
      • 8.4.3.1. Antivirals
      • 8.4.3.2. Antibiotics
      • 8.4.3.3. Antifungals
      • 8.4.3.4. Antiparasitic
      • 8.4.4. Global Anti-Infective Drugs Market, 2013-2017, Historic And Forecast Growth Rates, By Subsegment
      • 8.4.5. Global Anti-Infective Drugs Market Competitive Landscape
      • 8.4.6. Global Anti-Infective Drug Market Key Mergers and Acquisitions
    • 8.5. Metabolic Disorders Drugs
      • 8.5.1. Metabolic Disorders Drugs Market Characteristics
      • 8.5.2. Metabolic Disorders Drugs Market Trends & Strategies
      • 8.5.3. Global Metabolic Disorders Drugs Market, Segmentation By Subsegment
      • 8.5.3.1. Anti-diabetics Drugs
      • 8.5.3.2. Anti-thyroid drugs
      • 8.5.3.3. Others (Hyperparathyroidism, Hypopituitarism, Hypoadrenalism)
      • 8.5.4. Global Metabolic Disorders Drugs Market, 2013-2017, Historic And Forecast Growth Rate, By Subsegment
      • 8.5.5. Global Metabolic Disorder Drugs Market Competitive Landscape
      • 8.5.6. Global Metabolic Disorders Drugs Market Key Mergers And Acquisitions
    • 8.6. Central Nervous System Drugs
      • 8.6.1. Central Nervous System Drugs Market Characteristics
      • 8.6.2. Central Nervous System Drugs Market Trends & Strategies
      • 8.6.3. Global Central Nervous System Drugs Market, Segmentation By Subsegment
      • 8.6.3.1. Anesthetics
      • 8.6.3.2. Analgesics
      • 8.6.3.3. Anti-Parkinson drugs
      • 8.6.3.4. Anti-Epileptics
      • 8.6.3.5. Other CNS drugs
      • 8.6.4. Global Central Nervous System Drugs Market, 2013-2017, Historic And Forecast Growth Rate, By Subsegment
      • 8.6.5. Global Central Nervous System Market Competitive Landscape
      • 8.6.6. Global Central Nervous System Drugs Market Key Mergers And Acquisitions
    • 8.7. Genito-Urinary Drugs
      • 8.7.1. Genito-Urinary Drugs Market Characteristics
      • 8.7.2. Genito-Urinary Drugs Market Trends & Strategies
      • 8.7.3. Global Genito-Urinary Drugs Market, Segmentation By Subsegment
      • 8.7.3.1. Hormonal Contraceptives
      • 8.7.3.2. Drugs For Hormonal Replacement Therapy
      • 8.7.3.3. Drugs For Infections And Others
      • 8.7.3.4. Drugs for Benign prostatic hypertrophy
      • 8.7.3.5. Drugs For Erectile Dysfunction
      • 8.7.3.6. Drugs For Urinary Incontinence And Overactive Bladder
      • 8.7.3.7. Drugs for Infertility
      • 8.7.3.8. Diuretics
      • 8.7.4. Global Genito-Urinary Drugs Market, 2013-2017, Historic And Forecast Growth Rate, By Segment
      • 8.7.5. Global Genito-Urinary Drugs Market Competitive Landscape
      • 8.7.6. Genito-urinary Drugs Market Key Mergers And Acquisitions
    • 8.8. Respiratory Diseases
      • 8.8.1. Respiratory Diseases Drugs Market Characteristics
      • 8.8.2. Respiratory Diseases Drugs Market Trends & Strategies
      • 8.8.3. Global Respiratory Diseases Market, Segmentation By Subsegment
      • 8.8.3.1. Anti-Asthmatics And COPD Drugs
      • 8.8.3.2. Cough And Cold Preparations
      • 8.8.4. Global Respiratory Diseases Market, 2013-2017, Historic And Forecast Growth Rate, By Subsegment
      • 8.8.5. Global Respiratory Diseases Drugs Market Competitive Landscape
      • 8.8.6. Global Respiratory Drugs Market Key Mergers And Acquisitions
    • 8.9. Gastrointestinal Drugs
      • 8.9.1. Gastrointestinal Drugs Market Characteristics
      • 8.9.2. Gastrointestinal Drugs Market Trends & Strategies
      • 8.9.3. Global Gastrointestinal Drugs Market, Segmentation By Subsegment
      • 8.9.3.1. Antiulcerants
      • 8.9.3.2. Vitamins And Minerals
      • 8.9.3.3. Antacids
      • 8.9.3.4. Antiemetics And Antinauseants
      • 8.9.3.5. Antiobesity
      • 8.9.3.6. Antidiarrhoeals
      • 8.9.4. Global Gastrointestinal Drugs Market, 2013-2017, Historic And Forecast Growth Rate, By Subsegment
      • 8.9.5. Global Gastrointestinal Drugs Market Competitive Landscape
      • 8.9.6. Global Gastrointestinal Drugs Market Key Mergers And Acquisitions
    • 8.10. Hematology Drugs
      • 8.10.1. Hematology Drugs Market Characteristics
      • 8.10.2. Hematology Drugs Market Trends & Strategies
      • 8.10.3. Global Hematology Drugs Market, Segmentation By Subsegment
      • 8.10.3.1. Blood Products
      • 8.10.3.2. Anemia And Other Blood Disorder Drugs
      • 8.10.4. Global Hematology Drugs Market, 2013-2017, Historic And Forecast Growth Rate, By Subsegment
      • 8.10.5. Global Hematology Drugs Market Competitive Landscape
      • 8.10.6. Global Hematology Drugs Market Key Mergers And Acquisitions
    • 8.11. Dermatology Drugs
      • 8.11.1. Dermatology Drugs Market Characteristics
      • 8.11.2. Dermatology Drugs Market Trends & Strategies
      • 8.11.3. Global Dermatology Drugs Market Competitive Landscape
      • 8.11.4. Dermatology Drugs Market Key Mergers And Acquisitions
    • 8.12. Ophthalmology Drugs
      • 8.12.1. Ophthalmology Drugs Market Characteristics
      • 8.12.2. Ophthalmology Drugs Market Trends & Strategies
      • 8.12.3. Global Ophthalmology Drugs Market, Segmentation By Subsegment
      • 8.12.3.1. Antiglaucoma
      • 8.12.3.2. Dry Eye Medication
      • 8.12.3.3. Other Opthalmological Drugs
      • 8.12.4. Global Ophthalmology Drugs Market, 2013-2017, Historic And Forecast Growth Rate, By Subsegment
      • 8.12.5. Global Ophthalmology Drugs Market Competitive Landscape
      • 8.12.6. Ophthalmology Drugs Market Key Mergers And Acquisitions
  9. 9. Pharmaceutical Drugs Market Comparison With Macro Economic Factors
    • 9.1. Pharmaceutical Drugs Market Size And Percentage Of GDP, Global
    • 9.2. Per Capita Average Pharmaceutical Drugs Expenditure, Global
    • 9.3. Pharmaceutical Drugs Market Comparison With Macro Economic Factors Across Countries
    • 9.3.1. Pharmaceutical Drugs Market Size, Percentage Of GDP, By Country
    • 9.3.2. Per Capita Average Pharmaceutical Drugs Expenditure, By Country
  10. 10. Pharmaceutical Drugs Market Comparison With Industry Metrics
    • 10.1. Number Of General Practitioners 2017, By Country
    • 10.2. Average Pharmaceutical Drugs Revenue Per General Practitioner, 2017, By Country
    • 10.3. Number Of Pharmacists, 2017, By Country
    • 10.4. Average Pharmaceutical Drugs Revenue Per Pharmacist, 2017, By Country
    • 10.5. Number Of Employees In Pharmaceutical Industry, 2017, By Country
    • 10.6. Average Revenue Per Pharmaceutical Employee, 2017, By Country
    • 10.7. Number Of Pharmaceutical Enterprises, 2017, By Country
    • 10.8. Average Pharmaceutical Drugs Revenue Per Pharmaceutical Enterprise, 2017, By Country
    • 10.9. Number Of Pharmacies Per 100,000 Population, 2017, By Country
    • 10.10. Generic & Branded Sales Proportion By Country (Value), 2016, By Country
    • 10.11. New Drug Approvals, 2017, By Country
  11. 11. Asia-Pacific Pharmaceutical Drugs Market
    • 11.1. Asia-Pacific Pharmaceutical Drugs Market Overview
    • 11.2. Asia Pacific Pharmaceutical Market
    • 11.3. Asia Pacific Pharmaceutical Drugs Historic Market Growth
    • 11.4. Asia Pacific Pharmaceutical Drugs Market Forecast Growth
    • 11.5. Asia Pacific Pharmaceutical Drugs Market, Segmentation By Type
    • 11.6. Asia Pacific Pharmaceutical Drugs Market, 2013 - 2021, Historic And Forecast Growth Rates, Segmentation By Type
  12. 12. Asia-Pacific Pharmaceutical Drugs Market: Country Analysis
    • 12.1. China Pharmaceutical Drugs Market
      • 12.1.1. China Pharmaceutical Drugs Market Overview
      • 12.1.2. China Pharmaceutical Market
      • 12.1.3. China Pharmaceutical Drugs Historic Market Growth
      • 12.1.4. China Pharmaceutical Drugs Market Forecast Growth
      • 12.1.5. China Pharmaceutical Drugs Market, Segmentation By Type
      • 12.1.6. China Pharmaceutical Drugs Market, 2013 - 2021, Historic And Forecast Growth Rates, Segmentation By Type
    • 12.2. India Pharmaceutical Drugs Market
      • 12.2.1. India Pharmaceutical Drugs Market Overview
      • 12.2.2. India Pharmaceutical Market
      • 12.2.3. India Pharmaceutical Drugs Historic Market Growth
      • 12.2.4. India Pharmaceutical Drugs Market Forecast Growth
      • 12.2.5. India Pharmaceutical Drugs Market, Segmentation By Type
      • 12.2.6. India Pharmaceutical Drugs Market, 2013 - 2021, Historic And Forecast Growth Rates, Segmentation By Type
    • 12.3. Japan Pharmaceutical Drugs Market
      • 12.3.1. Japan Pharmaceutical Drugs Market Overview
      • 12.3.2. Japan Pharmaceutical Market
      • 12.3.3. Japan Pharmaceutical Drugs Historic Market Growth
      • 12.3.4. Japan Pharmaceutical Drugs Market Forecast Growth
      • 12.3.5. Japan Pharmaceutical Drugs Market, Segmentation By Type
      • 12.3.6. Japan Pharmaceutical Drugs Market, 2013 - 2021, Historic And Forecast Growth Rates, Segmentation By Type
    • 12.4. Australia Pharmaceutical Drugs Market
      • 12.4.1. Australia Pharmaceutical Market
      • 12.4.2. Australia Pharmaceutical Drugs Historic Market Growth
      • 12.4.3. Australia Pharmaceutical Drugs Market Forecast Growth
      • 12.4.4. Australia Pharmaceutical Drugs Market, Segmentation By Type
      • 12.4.5. Australia Pharmaceutical Drugs Market, 2013 - 2021, Historic And Forecast Growth Rates, Segmentation By Type
  13. 13. Western Europe Pharmaceutical Drugs Market
    • 13.1. Western Europe Pharmaceutical Drugs Market Overview
    • 13.2. Western Europe Pharmaceutical Market
    • 13.3. Western Europe Pharmaceutical Drugs Historic Market Growth
    • 13.4. Western Europe Pharmaceutical Drugs Market Forecast Growth
    • 13.5. Western Europe Pharmaceutical Drugs Market, Segmentation By Type
    • 13.6. Western Europe Pharmaceutical Drugs Market, 2013 - 2021, Historic And Forecast Growth Rates, Segmentation By Type
  14. 14. Western Europe Pharmaceutical Drugs Market: Country Analysis
    • 14.1. UK Pharmaceutical Drugs Market
      • 14.1.1. UK Pharmaceutical Drugs Market Overview
      • 14.1.2. UK Pharmaceutical Market
      • 14.1.3. UK Pharmaceutical Drugs Historic Market Growth
      • 14.1.4. UK Pharmaceutical Drugs Market Forecast Growth
      • 14.1.5. UK Pharmaceutical Drugs Market, Segmentation By Type
      • 14.1.6. UK Pharmaceutical Drugs Market, 2013 - 2021, Historic And Forecast Growth Rates, Segmentation By Type
    • 14.2. Germany Pharmaceutical Drugs Market
      • 14.2.1. Germany Pharmaceutical Market
      • 14.2.2. Germany Pharmaceutical Drugs Historic Market Growth
      • 14.2.3. Germany Pharmaceutical Drugs Market Forecast Growth
      • 14.2.4. Germany Pharmaceutical Drugs Market, Segmentation By Type
      • 14.2.5. Germany Pharmaceutical Drugs Market, 2013 - 2021, Historic And Forecast Growth Rates, Segmentation By Type
    • 14.3. France Pharmaceutical Drugs Market
      • 14.3.1. France Pharmaceutical Market
      • 14.3.2. France Pharmaceutical Drugs Market Historic Growth
      • 14.3.3.France Pharmaceutical Drugs Market Forecast Growth
      • 14.3.4.France Pharmaceutical Drugs Market, Segmentation By Type
      • 14.3.5.France Pharmaceutical Drugs Market, 2013 - 2021, Historic And Forecast Growth Rates, Segmentation By Type
    • 14.4.Italy Pharmaceutical Drugs Market
      • 14.4.1.Italy Pharmaceutical Market
      • 14.4.2.Italy Pharmaceutical Drugs Historic Market Growth
      • 14.4.3.Italy Pharmaceutical Drugs Market Forecast Growth
      • 14.4.4.Italy Pharmaceutical Drugs Market, Segmentation By Type
      • 14.4.5.Italy Pharmaceutical Drugs Market, 2013 - 2021, Historic And Forecast Growth Rates, Segmentation By Type
    • 14.5.Spain Pharmaceutical Drugs Market
      • 14.5.1.Spain Pharmaceutical Market
      • 14.5.2.Spain Pharmaceutical Drugs Historic Market Growth
      • 14.5.3.Spain Pharmaceutical Drugs Market Forecast Growth
      • 14.5.4.Spain Pharmaceutical Drugs Market, Segmentation By Type
      • 14.5.5.Spain Pharmaceutical Drugs Market, 2013 - 2021, Historic And Forecast Growth Rates, Segmentation By Type
  15. 15.Eastern Europe Pharmaceutical Drugs Market
    • 15.1.Eastern Europe Pharmaceutical Drugs Market Overview
    • 15.2.Eastern Europe Pharmaceutical Market
    • 15.3.Eastern Europe Pharmaceutical Drugs Historic Market Growth
    • 15.4.Eastern Europe Pharmaceutical Drugs Market Forecast Growth
    • 15.5.Eastern Europe Pharmaceutical Drugs Market, Segmentation By Type
    • 15.6.Eastern Europe Pharmaceutical Drugs Market, 2013 - 2021, Historic And Forecast Growth Rate, Segmentation By Type
    • 15.7.Eastern Europe Pharmaceutical Drugs Market: Country Analysis
      • 15.7.1.Russia Pharmaceutical Drugs Market
      • 15.7.2.Russia Pharmaceutical Drugs Historic Market Growth
      • 15.7.3.Russia Pharmaceutical Drugs Market Forecast Growth
      • 15.7.4.Russia Pharmaceutical Drugs Market, Segmentation By Type
      • 15.7.5.Russia Pharmaceutical Drugs Market, 2013 - 2021, Historic And Forecast Growth Rates, Segmentation By Type
  16. 16.North America Pharmaceutical Drugs Market
    • 16.1.North America Pharmaceutical Drugs Market Overview
    • 16.2.North America Pharmaceutical Market
    • 16.3.North America Pharmaceutical Drugs Historic Market Growth
    • 16.4.North America Pharmaceutical Drugs Market Forecast Growth
    • 16.5.North America Pharmaceutical Drugs Market, Segmentation By Type
    • 16.6.North America Pharmaceutical Drugs Market, 2013 - 2021, Historic And Forecast Growth Rates, Segmentation By Type
    • 16.7.North America Pharmaceutical Drugs Market: Country Analysis
      • 16.7.1.USA Pharmaceutical Drugs Market Overview
      • 16.7.2.USA Pharmaceutical Market
      • 16.7.3.USA Pharmaceutical Drugs Historic Market Growth
      • 16.7.4.USA Pharmaceutical Drugs Market Forecast Growth
      • 16.7.5.USA Pharmaceutical Drugs Market, Segmentation By Type
      • 16.7.6.USA Pharmaceutical Drugs Market, 2013 - 2021, Historic And Forecast Growth Rates, Segmentation By Type
  17. 17.South America Pharmaceutical Drugs Market
    • 17.1.South America Pharmaceutical Drugs Market Overview
    • 17.2.South America Pharmaceutical Market
    • 17.3.South America Pharmaceutical Drugs Historic Market Growth
    • 17.4.South America Pharmaceutical Drugs Market Forecast Growth
    • 17.5.South America Pharmaceutical Drugs Market, Segmentation By Type
    • 17.6.South America Pharmaceutical Drugs Market, 2013 - 2021, Historic And Forecast Growth Rates, Segmentation By Type
    • 17.7.South America Pharmaceutical Drugs Market: Country Analysis
      • 17.7.1.Brazil Pharmaceutical Drugs Market
      • 17.7.2.Brazil Pharmaceutical Market
      • 17.7.3.Brazil Pharmaceutical Drugs Historic Market Growth
      • 17.7.4.Brazil Pharmaceutical Drugs Market Forecast Growth
      • 17.7.5.Brazil Pharmaceutical Drugs Market, Segmentation By Type
      • 17.7.6.Brazil Pharmaceutical Drugs Market, 2013 - 2021, Historic And Forecast Growth Rates, Segmentation By Type
  18. 18.Middle East Pharmaceutical Drugs Market
    • 18.1.Middle East Pharmaceutical Drugs Market Overview
    • 18.2.Middle East Pharmaceutical Market
    • 18.3.Middle East Pharmaceutical Drugs Historic Market Growth
    • 18.4.Middle East Pharmaceutical Drugs Market Forecast Growth
    • 18.5.Middle East Pharmaceutical Drugs Market, Segmentation By Type
    • 18.6.Middle East Pharmaceutical Drugs Market, 2013 - 2021, Historic And Forecast Growth Rates, Segmentation By Type
  19. 19.Africa Pharmaceutical Drugs Market
    • 19.1.Africa Pharmaceutical Drugs Market Overview
    • 19.2.Africa Pharmaceutical Market
    • 19.3.Africa Pharmaceutical Drugs Historic Market Growth
    • 19.4.Africa Pharmaceutical Drugs Market Forecast Growth
    • 19.5.Africa Pharmaceutical Drugs Market, Segmentation By Type
    • 19.6.Africa Pharmaceutical Drugs Market, 2013 - 2021, Historic And Forecast Growth Rates, Segmentation By Type
  20. 20.Global Pharmaceutical Drugs Market Competitive Landscape
    • 20.1.Novartis AG
      • 20.1.1.Company Overview
      • 20.1.2.Products And Services
      • 20.1.3.Strategy
      • 20.1.4.Novartis AG Financial Performance
    • 20.2.Sanofi
      • 20.2.1.Company Overview
      • 20.2.2.Products And Services
      • 20.2.3.Strategy
      • 20.2.4.Sanofi S.A Financial Performance
    • 20.3.Pfizer Inc.
      • 20.3.1.Company Overview
      • 20.3.2.Products And Services
      • 20.3.3.Strategy
      • 20.3.4.Pfizer Inc.Financial Performance
    • 20.4.Gilead Sciences Inc.
      • 20.4.1.Company Overview
      • 20.4.2.Products And Services
      • 20.4.3.Strategy
      • 20.4.4.Gilead Sciences Inc.Financial Performance
  21. 21.Key Mergers And Acquisitions In The Pharmaceutical Drugs Market
  22. 22.Pharmaceutical Drugs Market Trends And Strategies
  23. 23.Market Background: Healthcare Market
    • 23.1.Healthcare Market Characteristics
    • 23.2.Global Healthcare Historic Market Growth
      • 23.2.1.Drivers Of The Market
      • 23.2.2.Restraints On The Market
    • 23.3.Global Healthcare Forecast Market Growth
      • 23.3.1.Drivers Of The Market
      • 23.3.2.Restraints On The Market
    • 23.4.Healthcare Market Geography Regional And Country Analysis
      • 23.4.1.Healthcare Market, 2017, By Region
      • 23.4.2.Healthcare Market, 2013 - 2021, Historic And Forecast Growth Rates, By Region
      • 23.4.3.Healthcare Market, 2017, By Country
      • 23.4.4.Healthcare Market, 2013 - 2021, Historic And Forecast Growth Rates, By Country
    • 23.5.Healthcare Market Segmentation, By Region, 2017
    • 23.6.Healthcare Market Segmentation, By Country, 2017
    • 23.7.Global Healthcare Market Comparison With Macro Economic Factors
      • 23.7.1.Global Healthcare Market Size, Percentage Of GDP
      • 23.7.2.Global Per Capita Average Healthcare Expenditure
      • 23.7.3.Healthcare Market Comparison With Macro Economic Factors Across Countries
        • 23.7.3.1.Healthcare Market Size, Percentage Of GDP, By Country
        • 23.7.3.2.Per Capita Average Healthcare Expenditure, By Country
      • 23.8.Key Mergers And Acquisitions In The Healthcare Market
      • 23.9.Healthcare Market Trends And Strategies
  24. 24.Appendix

List Of Tables

    Table 1: Global Pharmaceutical Drugs Market, Historic Market Size, 2013-2017 , $ Billion 31
  • Table 2: Global Pharmaceutical Drugs Market, Forecast Market Size, 2017-2021 , $ Billion 35
  • Table 3: Pharmaceutical Drugs Market, 2017, Split By Region 43
  • Table 4: Pharmaceutical Drugs Market, 2013-2017, Historic And Forecast Growth Rate, Split By Region 45
  • Table 5: Pharmaceutical Drugs Market, 2017, Split By Country 47
  • Table 6: Pharmaceutical Drugs Market, 2013-2017, Historic And Forecast Growth Rate, Split By Country 49
  • Table 7: Global Pharmaceutical Drugs  Market, Split By Segments, 2017, $ Billion 52
  • Table 8: Global Pharmaceutical Drugs Market, 2013-2017,  Historic And Forecast Growth Rate, Split By Segment 55
  • Table 9: Global Musculoskeletal Disorders Drugs Market, 2017, By Subsegment 61
  • Table 10: Global Pharmaceutical Drugs Market, 2013-2017, Historic And Forecast Growth Rate, Split By Subsegment 62
  • Table 11: Global Musculoskeletal Drugs Market, Key Competitor Market Shares And Revenues, 2017, 64
  • Table 12: Global Cardiovascular Drugs Market, 2017, Segmentation By Subsegment 72
  • Table 13: Global Cardiovascular Drugs Market, 2013-2017, Historic And Forecast Growth Rate, By Subsegment 73
  • Table 14: Global Cardiovascular Market, Competitor Market Shares and Revenues, 2017 75
  • Table 15: Global Oncology Drugs Market, 2017, Segmentation By Subegment 82
  • Table 16: Global Oncology Drugs Market, 2013-2017, Historic And Forecast Growth Rate, By Subsegment 85
  • Table 17: Global Oncology Drugs Market, Competitor Market Shares and Revenues, 2017 87
  • Table 18: Global Anti-Infective Drugs Market, 2017, Segmentation, By Subsegment 95
  • Table 19: Global Anti-Infective Drugs Market, 2013-2017, Historic And Forecast Growth Rate, By Subsegment 97
  • Table 20: Global Anti-Infective Drugs Market, Competitor Market Shares and Revenues, 2017 99
  • Table 21: Global Metabolic Disorders Drugs Market, 2017, Segmentation By Segment 107
  • Table 22: Global Metabolic Disorders Drugs Market, 2013-2017, Historic And Forecast Growth Rate, By Subsegment 108
  • Table 23: Global Metabolic Disorder Drugs Market, Competitor Market Shares and Revenues, 2017 110
  • Table 24: Global Central Nervous System Drugs Market, 2017, Segmentation By Segment 117
  • Table 25: Global Central Nervous System Drugs Market, 2013-2017, Historic And Forecast Growth Rate, By Subsegment 119
  • Table 26: Global Central Nervous System Drugs Market, Competitor Market Shares and Revenues, 2017 121
  • Table 27: Global Genito-Urinary Drugs Market, 2017, Segmentation By Subsegment 129
  • Table 28: Global Genito-Urinary Drugs Market, 2013-2017, Historic And Forecast Growth Rate, By Subsegment 131
  • Table 29: Global Genito-Urinary Drugs Market, Competitor Market Shares And Reveneues, 2017 133
  • Table 30: Global Respiratory Diseases Market, 2017, Segmentation By Subsegment 142
  • Table 31: Global Respiratory Diseases Market, 2013-2017, Historic And Forecast Growth Rate, By Segment 143
  • Table 32: Global Respiratory Diseases Drugs Market, Competitor Market Shares And Revenues, 2017 144
  • Table 33: Global Gastrointestinal Drugs Market, 2017, Segmentation By Subsegment 151
  • Table 34: Global Gastrointestinal Drugs Market, 2013-2017, Historic And Forecast Growth Rate, By Segment 153
  • Table 35: Global Gastrointestinal Drugs Market, Competitor Market Shares And Revenues, 2017 155
  • Table 36: Global Hematology Drugs Market, 2017, Segmentation By Subsegment 163
  • Table 37: Global Hematology Drugs Market, 2013-2017, Historic And Forecast Growth Rate, By Subsegment 164
  • Table 38: Global Hematology Drugs Market, Competitor Market Shares And Revenues, 2017 165
  • Table 39: Global Dermatology Drugs Market, Competitor Market Shares And Revenues, 2017 173
  • Table 40: Global Ophthalmology Drugs Market, 2017, Segmentation, By Subsegment 181
  • Table 41: Global Ophthalmology Drugs Market, 2013-2017, Historic And Forecast Growth Rate, By Subsegment 183
  • Table 42: Global Ophthalmology Drugs Market, Competitor Market Shares And Revenues, 2017 184
  • Table 43: Pharmaceutical Drugs Market Size And Percentage Of GDP, Global 189
  • Table 44: Per Capita Average Pharmaceutical Drugs Expenditure, Global 190
  • Table 45: Pharmaceutical Drugs Market Size, Percentage Of GDP, By Country, 2017 191
  • Table 46: Per Capita Average Pharmaceutical Drugs Expenditure, By Country, 2017 192
  • Table 47: Number Of General Practitioners 2017, By Country, Thousands 194
  • Table 48: Average Revenue Per  General Practitioner, 2017, By Country, $ Thousands 196
  • Table 49: l Number Of Pharmacies Per 100,000 Population, 2017, By Country 197
  • Table 50: Number Of Pharmacists, 2017, By Country, Thousands 198
  • Table 51: Average Revenue Per  Pharmacist, 2017, By Country, $Thousands 199
  • Table 52: Number Of Employees In Pharmaceutical Industry (in Thousands), 2017, By Country 200
  • Table 53: Average Revenue Per  Pharmaceutical Employee, 2017, By Country, $ Thousands 202
  • Table 54: Number Of Pharmaceutical Enterprises, 2017, By Country 203
  • Table 55: Average Revenue Per  Pharmaceutical Enterprises, 2017, By Country, $ Million 204
  • Table 56: Generic & Branded Sales Proportion By Country (Value), 2017 207
  • Table 57: New Drug Approvals, 2017, By Country 208
  • Table 58: Asia Pacific Pharmaceutical Drugs Market, Historic Market Size, 2013-2017 , $ Billion 215
  • Table 59: Asia Pacific Pharmaceutical Drugs Market, Forecast Market Size, 2017-2021 , $ Billion 216
  • Table 60: Asia Pacific Pharmaceutical Drugs Market, Segmentation By Type, 2017 217
  • Table 61: Asia Pacific Pharmaceutical Drugs Market, 2013 - 2021, Historic And Forecast Growth Rates, Segmentation By Type 219
  • Table 62: China Pharmaceutical Drugs Market, Historic Market Size, 2013-2017 , $ Billion 224
  • Table 63: China Pharmaceutical Drugs Market, Forecast Market Size, 2017-2021 , $ Billion 226
  • Table 64: China Pharmaceutical Drugs Market, Segmentation, By Type, 2017 227
  • Table 65: China Pharmaceutical Drugs Market, 2013 - 2021, Historic And Forecast Growth Rates, Segmentation By Type 229
  • Table 66: India Pharmaceutical Drugs Market, Historic Market Size, 2013-2017 , $ Billion 234
  • Table 67: India Pharmaceutical Drugs Market, Forecast Market Size, 2017-2021 , $ Billion 236
  • Table 68: India Pharmaceutical Drugs Market, Segmentation By Type, 2017 237
  • Table 69: India Pharmaceutical Drugs Market, 2013 - 2021, Historic And Forecast Growth Rates, Segmentation By Type 239
  • Table 70: Japan Pharmaceutical Drugs Market, Historic Market Size, 2013-2017 , $ Billion 244
  • Table 71: Japan Pharmaceutical Drugs Market, Forecast Market Size, 2017-2021 , $ Billion 246
  • Table 72: Japan Pharmaceutical Drugs Market, Segmentation By Type, 2017 247
  • Table 73: Japan Pharmaceutical Drugs Market, 2013 - 2021, Historic And Forecast Growth rates, Segmentation By Type 249
  • Table 74: Australia Pharmaceutical Drugs Market, Historic Market Size, 2013-2017 , $ Billion 250
  • Table 75: Australia Pharmaceutical Drugs Market, Forecast Market Size, 2017-2021 , $ Billion 252
  • Table 76: Australia Pharmaceutical Drugs Market, Segmentation By Type, 2017 253
  • Table 77: Australia Pharmaceutical Drugs Market, 2013 - 2021, Historic And Forecast Growth Rates, Segmentation By Type 255
  • Table 78: Western Europe Pharmaceutical Drugs Market, Historic Market Size, 2013-2017 , $ Billion 260
  • Table 79: Western Europe Pharmaceutical Drugs Market, Forecast Market Size, 2017-2021 , $ Billion 261
  • Table 80: Western Europe Pharmaceutical Drugs Market, Segmentation By Type 262
  • Table 81: Western Europe Pharmaceutical Drugs Market, 2013 - 2021, Historic And Forecast Growth Rates, Segmentation By Type 264
  • Table 82: UK Pharmaceutical Drugs Market, Historic Market Size, 2013-2017 , $ Billion 268
  • Table 83: UK Pharmaceutical Drugs Market, Forecast Market Size, 2017-2021 , $ Billion 270
  • Table 84: UK Pharmaceutical Drugs Market, Segmentation By Type, 2017 271
  • Table 85: UK Pharmaceutical Drugs Market, 2013 - 2021, Historic And Forecast Growth Rates, Segmentation By Type 273
  • Table 86: Germany Pharmaceutical Drugs Market, Historic Market Size, 2013-2017 , $ Billion 276
  • Table 87: Germany Pharmaceutical Drugs Market, Forecast Market Size, 2017-2021 , $ Billion 277
  • Table 88: Germany Pharmaceutical Drugs Market, Segmentation By Type, 2017 278
  • Table 89: Germany Pharmaceutical Drugs Market, 2013 - 2021, Historic And Forecast Growth Rates, Segmentation By Type 280
  • Table 90: France Pharmaceutical Drugs Market, Historic Market Size, 2013-2017 , $ Billion 282
  • Table 91: France Pharmaceutical Drugs Market, Forecast Market Size, 2017-2021 , $ Billion 284
  • Table 92: France Pharmaceutical Drugs Market, Segmentation By Type, 2017 285
  • Table 93: France Pharmaceutical Drugs Market, 2013 - 2021, Historic And Forecast Growth Rates, Segmentation By Type 287
  • Table 94: Italy Pharmaceutical Drugs Market, Historic Market Size, 2013-2017 , $ Billion 290
  • Table 95: Italy Pharmaceutical Drugs Market, Forecast Market Size, 2017-2021 , $ Billion 291
  • Table 96: Italy Pharmaceutical Drugs Market, Segmentation By Type, 2017 292
  • Table 97: Italy Pharmaceutical Drugs Market, 2013 - 2021, Historic And Forecast Growth Rates, Segmentation By Type 294
  • Table 98: Spain Pharmaceutical Drugs Market, Historic Market Size, 2013-2017 , $ Billion 296
  • Table 99: Spain Pharmaceutical Drugs Market, Forecast Market Size, 2017-2021 , $ Billion 297
  • Table 100: Spain Pharmaceutical Drugs Market, Segmentation By Type, 2017 298
  • Table 101: Spain Pharmaceutical Drugs Market, 2013 - 2021, Historic And Forecast Growth Rates, Segmentation By Type 300
  • Table 102: Eastern Europe Pharmaceutical Drugs Market, Historic Market Size, 2013-2017 , $ Billion 303
  • Table 103: Eastern Europe Pharmaceutical Drugs Market, Forecast Market Size, 2017-2021 , $ Billion 305
  • Table 104: Eastern Europe Pharmaceutical Drugs Market, Segmentation By Type, 2017 306
  • Table 105: Eastern Europe Pharmaceutical Drugs Market, 2013 - 2021, Historic And Forecast Growth Rate, Segmentation By Type 308
  • Table 106: Russia Pharmaceutical Drugs Market, Historic Market Size, 2013-2017 , $ Billion 310
  • Table 107: Russia Pharmaceutical Drugs Market, Forecast Market Size, 2017-2021 , $ Billion 311
  • Table 108: Russia Pharmaceutical Drugs Market, Segmentation By Type, 2017 312
  • Table 109: Russia Pharmaceutical Drugs Market, 2013 - 2021, Historic And Forecast Growth Rates, Segmentation By Type 314
  • Table 110: North America Pharmaceutical Drugs Market, Historic Market Size, 2013-2017 , $ Billion 319
  • Table 111: North America Pharmaceutical Drugs Market, Forecast Market Size, 2017-2021 , $ Billion 321
  • Table 112: North America Pharmaceutical Drugs Market, Segmentation By Type, 2017 322
  • Table 113: North America Pharmaceutical Drugs Market, 2013 - 2021, Historic And Forecast Growth Rates, Segmentation By Type 324
  • Table 114: USA Pharmaceutical Drugs Market, Historic Market Size, 2013-2017 , $ Billion 329
  • Table 115: USA Pharmaceutical Drugs Market, Forecast Market Size, 2017-2021 , $ Billion 330
  • Table 116: USA Pharmaceutical Drugs Market, Segmentation By Type, 2017 331
  • Table 117: USA Pharmaceutical Drugs Market, 2013 - 2021, Historic And Forecast Growth Rates, Segmentation By Type 333
  • Table 118: South America Pharmaceutical Drugs Market, Historic Market Size, 2013-2017 , $ Billion 339
  • Table 119: South America Pharmaceutical Drugs Market, Forecast Market Size, 2017-2021 , $ Billion 340
  • Table 120: South America Pharmaceutical Drugs Market, Segmentation By Type, 2017 341
  • Table 121: South America Pharmaceutical Drugs Market, 2013 - 2021, Historic And Forecast Growth Rates, Segmentation By Type 343
  • Table 122: Brazil Pharmaceutical Drugs Market, Historic Market Size, 2013-2017 , $ Billion 345
  • Table 123: Brazil Pharmaceutical Drugs Market, Forecast Market Size, 2017-2021 , $ Billion 346
  • Table 124: Brazil Pharmaceutical Drugs Market, Segmentation By Type, 2017 347
  • Table 125: Brazil Pharmaceutical Drugs Market, 2013 - 2021, Historic And Forecast Growth Rates, Segmentation By Type 349
  • Table 126: Middle East Pharmaceutical Drugs Market, Historic Market Size, 2013-2017 , $ Billion 352
  • Table 127: Middle East Pharmaceutical Drugs Market, Forecast Market Size, 2017-2021 , $ Billion 354
  • Table 128: Middle East Pharmaceutical Drugs Market, Segmentation By Type, 2017 355
  • Table 129: Middle East Pharmaceutical Drugs Market, 2013 - 2021, Historic And Forecast Growth Rates, Segmentation By Type 357
  • Table 130: Africa Pharmaceutical Drugs Market, Historic Market Size, 2013-2017 , $ Billion 361
  • Table 131: Africa Pharmaceutical Drugs Market, Forecast Market Size, 2017-2021 , $ Billion 363
  • Table 132: Africa Pharmaceutical Drugs Market, Segmentation By Type, 2017 364
  • Table 133: Africa Pharmaceutical Drugs Market, 2013 - 2021, Historic And Forecast Growth Rates, Segmentation By Type 366
  • Table 134: Global Pharmaceutical Drugs Market, Competitor Market Shares And Revenues, 2017 368
  • Table 135: Novartis AG Financial Performance 371
  • Table 136: Sanofi S.A Financial Performance 373
  • Table 137: Pfizer Financial Performance 375
  • Table 138: Gilead Sciences Financial Performance 377
  • Table 139: Global Healthcare Market, Historic Market Size, 2013-2017 , $ Billion 384
  • Table 140: Global Healthcare Market, Forecast Market Size, 2013-2017 , $ Billion 387
  • Table 141: Healthcare Market, 2017, Split By Region 391
  • Table 142: Healthcare Market, 2013-2017, Historic And Forecast Growth Rate, Split By Region 392
  • Table 143: Healthcare Market, 2017, Split By Country 394
  • Table 144: Healthcare Market, 2013-2017, Historic And Forecast Growth Rate, Split By Country 396
  • Table 145: Healthcare Market Segmentation, By Region,  2017 398
  • Table 146: Healthcare Market Segmentation, By Country,  2017 399
  • Table 147: Healthcare Market Size, Percentage Of GDP, Global 401
  • Table 148: Global Per Capita Average Healthcare Expenditure 402
  • Table 149: Healthcare Market Size, Percentage Of GDP, By Country 403
  • Table 150: Per Capita Average Healthcare Expenditure, By Country 404
  • Table 151: Global Pharmaceutical Drugs Market, Market Data Sources 409

List Of Figures

    Figure 1: Global Pharmaceutical Drugs Market, Historic Market Size, 2013-2017 , $ Billion 31
  • Figure 2: Global Pharmaceutical Drugs Market, Forecast Market Size, 2017-2021 , $ Billion 35
  • Figure 3: Global Pharmaceutical Drugs Market, PESTLE Analysis 38
  • Figure 4: Pharmaceutical Drugs Market, 2017, Split By Region 43
  • Figure 5: Pharmaceutical Drugs Market, 2013-2017, Historic And Forecast Growth Rate, Split By Region 45
  • Figure 6: Pharmaceutical Drugs Market, 2017, Split By Country 46
  • Figure 7: Pharmaceutical Drugs Market, 2013-2017, Historic And Forecast Growth Rate, Split By Country 49
  • Figure 8: Global Pharmaceutical Drugs  Market, Split By Segments, 2017, $ Billion 51
  • Figure 9: Global Pharmaceutical Drugs Market, 2013-2017, Historic And Forecast Growth Rate, Split By Segment 55
  • Figure 10: Global Musculoskeletal Disorders Drugs Market, Segmentation By Subsegment 61
  • Figure 11: Global Musculoskeletal Disorders Drugs Market, 2013-2017, Historic And Forecast Growth Rate, Split By Subsegment 62
  • Figure 12: Global Musculoskeletal Drugs Market, Key Competitor Market Shares, 2017, Percentage (%) 64
  • Figure 13: Global Cardiovascular Drugs Market, Segmentation By Subsegment 72
  • Figure 14: Global Cardiovascular Drugs Market, 2013-2017, Historic And Forecast Growth Rate, By Subsegment 73
  • Figure 15: Global Cardiovascular Drugs Market, Key Competitor Market Shares, 2017, Percentage (%) 75
  • Figure 16: Global Oncology Drugs Market, Segmentation By Subsegment 82
  • Figure 17: Global Oncology Drugs Market, 2013-2017, Historic And Forecast Growth Rate, By Subsegment 85
  • Figure 18: Global Oncology Drugs Market, Key Competitor  Market Shares, 2017, Percentage (%) 87
  • Figure 19: Global Anti-Infective Drugs Market, Segmentation By Subsegment 95
  • Figure 20: Global Anti-Infective Drugs Market, 2013-2017, Historic And Forecast Growth Rate, By Subsegment 97
  • Figure 21: Global Anti-Infective Drugs Market, Key Competitor Market Shares, 2017, Percentages (%) 99
  • Figure 22: Global Metabolic Disorders Drugs Market, Segmentation By Subsegment 107
  • Figure 23: Global Metabolic Disorders Drugs Market, 2013-2017, Historic And Forecast Growth Rate, By Subsegment 108
  • Figure 24: Global Metabolic Disorder Drugs Market, Key Competitor Market Shares, 2017, Percentage (%) 110
  • Figure 25: Global Central Nervous System Drugs Market, Segmentation By Subsegment 117
  • Figure 26: Global Central Nervous System Drugs Market, 2013-2017, Historic And Forecast Growth Rate, By Subsegment 119
  • Figure 27: Global Central Nervous System Market, Key Competitor Market Shares, 2017, Percentage (%) 121
  • Figure 28: Global Genito-Urinary Drugs Market, Segmentation By Subsegment 129
  • Figure 29: Global Genito-Urinary Drugs Market, 2013-2017, Historic And Forecast Growth Rate, By Segment 131
  • Figure 30: Global Genito-Urinary Drugs Market, Key Competitor Market Shares, 2017, Percentage (%) 133
  • Figure 31: Global Respiratory Diseases Market, Segmentation By Subsegment 142
  • Figure 32: Global Respiratory Diseases Market, 2013-2017, Historic And Forecast Growth Rate, By Subsegment 143
  • Figure 33: Global Respiratory Diseases Drugs Market, Key Competitor Market Shares, 2017, Percentage (%) 144
  • Figure 34: Global Gastrointestinal Drugs Market, Segmentation By Subsegment 151
  • Figure 35: Global Gastrointestinal Drugs Market, 2013-2017, Historic And Forecast Growth Rate, By Subsegment 153
  • Figure 36: Global Gastrointestinal Drugs Market, Key Competitor Market Shares, 2017, Percentage (%) 155
  • Figure 37: Global Hematology Drugs Market, Segmentation By Subsegment 163
  • Figure 38: Global Hematology Drugs Market, 2013-2017, Historic And Forecast Growth Rate, By Subsegment 164
  • Figure 39: Global Hematology Drugs Market, Key Competitor Market Shares, 2017, Percentage (%) 165
  • Figure 40: Global Dermatology Drugs Market, Key Competitor Market Shares, 2017, Percentage (%) 173
  • Figure 41: Global Ophthalmology Drugs Market, Segmentation By Subsegment 181
  • Figure 42: Global Ophthalmology Drugs Market, 2013-2017, Historic And Forecast Growth Rate, By Subsegment 183
  • Figure 43: Global Ophthalmology Drugs Market, Key Competitor Market Shares, 2017, Percentage (%) 184
  • Figure 44: Pharmaceutical Drugs Market Size And Percentage Of GDP, Global 189
  • Figure 45: Per Capita Average Pharmaceutical Drugs Expenditure, Global 190
  • Figure 46: Pharmaceutical Drugs Market Size, Percentage Of GDP, By Country 191
  • Figure 47: Per Capita Average Pharmaceutical Drugs Expenditure, By Country 192
  • Figure 48: Number Of General Practitioners 2017, By Country, Thousands 194
  • Figure 49: Average Revenue Per General Practitioner, 2017, By Country, $ Thousands 196
  • Figure 50: Number Of Pharmacies Per 100,000 Population, 2017, By Country 197
  • Figure 51: Number Of Pharmacists, 2017, By Country, Thousands 198
  • Figure 52: Average Revenue Per Pharmacist, 2017, By Country, $Thousands 199
  • Figure 53: Number Of Employees In Pharmaceutical Industry, 2017, By Country, Thousands 200
  • Figure 54: Average Revenue Per Pharmaceutical Employee, 2017, By Country, $ Thousands 202
  • Figure 55: Number Of Pharmaceutical Enterprises, 2017, By Country 203
  • Figure 56: Average Revenue Per Pharmaceutical Enterprises, 2017, By Country, $ Million 204
  • Figure 57: Generic & Branded Sales Proportion By Country (Value), 2017 207
  • Figure 58: New Drug Approvals, 2017, By Country 208
  • Figure 59: Asia Pacific Pharmaceutical Drugs Market, Historic Market Size, 2013-2017 , $ Billion 214
  • Figure 60: Asia Pacific Pharmaceutical Drugs Market, Forecast Market Size, 2017-2021 , $ Billion 216
  • Figure 61: Asia Pacific Pharmaceutical Drugs Market, Segmentation By Type, 2017 217
  • Figure 62: Asia Pacific Pharmaceutical Drugs Market, 2013 - 2021, Historic And Forecast Growth Rates, Segmentation By Type 218
  • Figure 63: China Pharmaceutical Drugs Market, Historic Market Size, 2013-2017 , $ Billion 224
  • Figure 64: China Pharmaceutical Drugs Market, Forecast Market Size, 2017-2021 , $ Billion 226
  • Figure 65: China Pharmaceutical Drugs Market, Segmentation By Type, 2017 227
  • Figure 66: China Pharmaceutical Drugs Market, 2013 - 2021, Historic And Forecast Growth Rates, Segmentation By Type 228
  • Figure 67: India Pharmaceutical Drugs Market, Historic Market Size, 2013-2017 , $ Billion 234
  • Figure 68: India Pharmaceutical Drugs Market, Forecast Market Size, 2017-2021 , $ Billion 236
  • Figure 69: India Pharmaceutical Drugs Market, Segmentation By Type, 2017 237
  • Figure 70: India Pharmaceutical Drugs Market, 2013 - 2021, Historic And Forecast Growth Rates, Segmentation By Type 238
  • Figure 71: Japan Pharmaceutical Drugs Market, Historic Market Size, 2013-2017 , $ Billion 244
  • Figure 72: Japan Pharmaceutical Drugs Market, Forecast Market Size, 2017-2021 , $ Billion 246
  • Figure 73: Japan Pharmaceutical Drugs Market, Segmentation By Type, 2017 247
  • Figure 74: Japan Pharmaceutical Drugs Market, 2013 - 2021, Historic And Forecast Growth Rates, Segmentation By Type 248
  • Figure 75: Australia Pharmaceutical Drugs Market, Historic Market Size, 2013-2017 , $ Billion 250
  • Figure 76: Australia Pharmaceutical Drugs Market, Forecast Market Size, 2017-2021 , $ Billion 252
  • Figure 77: Australia Pharmaceutical Drugs Market, Segmentation By Type, 2017 253
  • Figure 78: Australia Pharmaceutical Drugs Market, 2013 - 2021, Historic And Forecast Growth Rates, Segmentation By Type 254
  • Figure 79: Western Europe Pharmaceutical Drugs Market, Historic Market Size, 2013-2017 , $ Billion 260
  • Figure 80: Western Europe Pharmaceutical Drugs Market, Forecast Market Size, 2017-2021 , $ Billion 261
  • Figure 81: Western Europe Pharmaceutical Drugs Market, Segmentation By Type 262
  • Figure 82: Western Europe Pharmaceutical Drugs Market, 2013 - 2021, Historic And Forecast Growth rates, Segmentation By Type 264
  • Figure 83: UK Pharmaceutical Drugs Market, Historic Market Size, 2013-2017 , $ Billion 268
  • Figure 84: UK Pharmaceutical Drugs Market, Forecast Market Size, 2017-2021 , $ Billion 270
  • Figure 85: UK Pharmaceutical Drugs Market, Segmentation By Type, 2017 271
  • Figure 86: UK Pharmaceutical Drugs Market, 2013 - 2021, Historic And Forecast Growth Rates, Segmentation By Type 273
  • Figure 87: Germany Pharmaceutical Drugs Market, Historic Market Size, 2013-2017 , $ Billion 275
  • Figure 88: Germany Pharmaceutical Drugs Market, Forecast Market Size, 2017-2021 , $ Billion 277
  • Figure 89: Germany Pharmaceutical Drugs Market, Segmentation By Type, 2017 278
  • Figure 90: Germany Pharmaceutical Drugs Market, 2013 - 2021, Historic And Forecast Growth Rates, Segmentation By Type 280
  • Figure 91: France Pharmaceutical Drugs Market, Historic Market Size, 2013-2017 , $ Billion 282
  • Figure 92: France Pharmaceutical Drugs Market, Forecast Market Size, 2017-2021 , $ Billion 284
  • Figure 93: France Pharmaceutical Drugs Market, Segmentation By Type, 2017 285
  • Figure 94: France Pharmaceutical Drugs Market, 2013 - 2021, Historic And Forecast Growth Rates, Segmentation By Type 287
  • Figure 95: Italy Pharmaceutical Drugs Market, Historic Market Size, 2013-2017 , $ Billion 289
  • Figure 96: Italy Pharmaceutical Drugs Market, Forecast Market Size, 2017-2021 , $ Billion 291
  • Figure 97: Italy Pharmaceutical Drugs Market, Segmentation By Type, 2017 292
  • Figure 98: Italy Pharmaceutical Drugs Market, 2013 - 2021, Historic And Forecast Growth Rates, Segmentation By Type 293
  • Figure 99: Spain Pharmaceutical Drugs Market, Historic Market Size, 2013-2017 , $ Billion 296
  • Figure 100: Spain Pharmaceutical Drugs Market, Forecast Market Size, 2017-2021 , $ Billion 297
  • Figure 101: Spain Pharmaceutical Drugs Market, Segmentation By Type, 2017 298
  • Figure 102: Spain Pharmaceutical Drugs Market, 2013 - 2021, Historic And Forecast Growth Rates, Segmentation By Type 299
  • Figure 103: Eastern Europe Pharmaceutical Drugs Market, Historic Market Size, 2013-2017 , $ Billion 303
  • Figure 104: Eastern Europe Pharmaceutical Drugs Market, Forecast Market Size, 2017-2021 , $ Billion 305
  • Figure 105: Eastern Europe Pharmaceutical Drugs Market, Segmentation By Type, 2017 306
  • Figure 106: Eastern Europe Pharmaceutical Drugs Market, 2013 - 2021, Historic And Forecast Growth Rate, Segmentation By Type 307
  • Figure 107: Russia Pharmaceutical Drugs Market, Historic Market Size, 2013-2017 , $ Billion 310
  • Figure 108: Russia Pharmaceutical Drugs Market, Forecast Market Size, 2017-2021 , $ Billion 311
  • Figure 109: Russia Pharmaceutical Drugs Market, Segmentation By Type, 2017 312
  • Figure 110: Russia Pharmaceutical Drugs Market, 2013 - 2021, Historic And Forecast Growth Rates, Segmentation By Type 314
  • Figure 111: North America Pharmaceutical Drugs Market, Historic Market Size, 2013-2017 , $ Billion 319
  • Figure 112: North America Pharmaceutical Drugs Market, Forecast Market Size, 2017-2021 , $ Billion 321
  • Figure 113: North America Pharmaceutical Drugs Market, Segmentation By Type, 2017 322
  • Figure 114: North America Pharmaceutical Drugs Market, 2013 - 2021, Historic And Forecast Growth Rates, Segmentation By Type 324
  • Figure 115: USA Pharmaceutical Drugs Market, Historic Market Size, 2013-2017 , $ Billion 329
  • Figure 116: USA Pharmaceutical Drugs Market, Forecast Market Size, 2017-2021 , $ Billion 330
  • Figure 117: USA Pharmaceutical Drugs Market, Segmentation By Type, 2017 331
  • Figure 118: USA Pharmaceutical Drugs Market, 2013 - 2021, Historic And Forecast Growth Rates, Segmentation By Type 333
  • Figure 119: South America Pharmaceutical Drugs Market, Historic Market Size, 2013-2017 , $ Billion 338
  • Figure 120: South America Pharmaceutical Drugs Market, Forecast Market Size, 2017-2021 , $ Billion 340
  • Figure 121: South America Pharmaceutical Drugs Market, Segmentation By Type, 2017 341
  • Figure 122: South America Pharmaceutical Drugs Market, 2013 - 2021, Historic And Forecast Growth Rates, Segmentation By Type 343
  • Figure 123: Brazil Pharmaceutical Drugs Market, Historic Market Size, 2013-2017 , $ Billion 345
  • Figure 124: Brazil Pharmaceutical Drugs Market, Forecast Market Size, 2017-2021 , $ Billion 346
  • Figure 125: Brazil Pharmaceutical Drugs Market, Segmentation By Type, 2017 347
  • Figure 126: Brazil Pharmaceutical Drugs Market, 2013 - 2021, Historic And Forecast Growth Rates, Segmentation By Type 348
  • Figure 127: Middle East Pharmaceutical Drugs Market, Historic Market Size, 2013-2017 , $ Billion 352
  • Figure 128: Middle East Pharmaceutical Drugs Market, Forecast Market Size, 2017-2021 , $ Billion 354
  • Figure 129: Middle East Pharmaceutical Drugs Market, Segmentation By Type, 2017 355
  • Figure 130: Middle East Pharmaceutical Drugs Market, 2013 - 2021, Historic And Forecast Growth Rates, Segmentation By Type 357
  • Figure 131: Africa Pharmaceutical Drugs Market, Historic Market Size, 2013-2017 , $ Billion 361
  • Figure 132: Africa Pharmaceutical Drugs Market, Forecast Market Size, 2017-2021 , $ Billion 363
  • Figure 133: Africa Pharmaceutical Drugs Market, Segmentation By Type, 2017 364
  • Figure 134: Africa Pharmaceutical Drugs Market, 2013 - 2021, Historic And Forecast Growth Rates, Segmentation By Type 366
  • Figure 135: Global Pharmaceutical Drugs Market, Key Competitor Market Shares, 2017, Percentage (%) 368
  • Figure 136: Novartis AG Financial Performance 371
  • Figure 137: Sanofi Financial Performance 373
  • Figure 138: Pfizer Inc. Financial Performance 375
  • Figure 139: Gilead Sciences Inc. Financial Performance 377
  • Figure 140: Global Healthcare Market, Historic Market Size, 2013-2017 , $ Billion 384
  • Figure 141: Global Healthcare Market, Forecast Market Size, 2013-2017 , $ Billion 387
  • Figure 142: Healthcare Market, 2017, By Region 390
  • Figure 143: Healthcare Market, 2013 - 2021, Historic And Forecast Growth Rates, By Region 392
  • Figure 144: Healthcare Market, 2017, By Country 394
  • Figure 145: Healthcare Market, 2013 - 2021, Historic And Forecast Growth Rates, By Country 396
  • Figure 146: Healthcare Market Segmentation, By Region,  2017 398
  • Figure 147: Healthcare Market Segmentation, By Country,  2017 399
  • Figure 148: Global Healthcare Market Size, Percentage Of GDP 401
  • Figure 149: Global Per Capita Average Healthcare Expenditure 402
  • Figure 150: Global Healthcare Market Size, Percentage Of GDP, By Country 403
  • Figure 151: Per Capita Average Healthcare Expenditure, By Country 404
Research Initiatives And Funding And Demand For New Medicines For Drug-Resistant Infections In The Anti-Infective Drugs Industry
Global Biologics Market, Opportunities And Strategies Market | Characteristics, Forecast Size, Trends
Biologics Market By Types (Monoclonal Antibodies, Therapeutic Proteins And Vaccines), By Trends, By Regions and By Key Players - Global Forecast To 2021
View Report
Pharmaceutical Drugs Market By Segments (Musculoskeletal Disorders Drugs, Cardiovascular Drugs, Oncology Drugs, Anti-Infective Drugs, Metabolic Disorder Drugs, Central Nervous System Drugs, Genito-Urinary Drugs, Respiratory Diseases Drugs, Gastrointestinal Drugs, Hematology Drugs, Dermatology Drugs, Ophthalmology Drugs) - Global Forecast To 2022
View Report
Cardiovascular Drugs Global Market Report 2019
View Report
Dermatology Drugs Global Market Report 2019
View Report
Gastrointestinal Drugs Global Market Report 2019
View Report
Hematology Drugs Global Market Report 2019
View Report
Metabolic Disorders Drugs Global Market Report 2019
View Report
Musculoskeletal Disorders Drugs Global Market Report 2019
View Report

Call Us

+1 3156230293

(Americas)

+44 2071930708

(Europe)

+91 8897263534

(Asia & Others)